Patent Assignment
Reel/Frame 065317/0816
Assignment of Assignor's Interest
Recorded: 2023-10-23
Pages: 6
Assignor
BORODIC, GARY E.
Executed: 2016-03-23
Assignee
BOTULINUM TOXIN RESEARCH ASSOCIATES, INC.
1261 FURNACE BROOK PARKWAY, QUINCY, MASSACHUSETTS, 02169
Covered Property
(1)
Botulinum Toxin and the Treatment of Primary Disorders of Mood and Affect
Application:
17/135,938 →
Publication:
US 2021/0252116
Related Assignments
(6)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Interest
Mar 18, 2022
From: REVANCE THERAPEUTICS, INC.
To: ATHYRIUM BUFFALO LP
Reel/Frame 059437/0654 →
Assignment of Assignor's Interest
Oct 23, 2023
From: BOTULINUM TOXIN RESEARCH ASSOCIATES, INC.
To: REVANCE THERAPEUTICS, INC.
Reel/Frame 065317/0047 →
Release of Security Interest
Feb 7, 2025
From: ATHYRIUM BUFFALO LP
To: REVANCE THERAPEUTICS, INC
Reel/Frame 070153/0630 →
Security Interest
Feb 7, 2025
From: REVANCE THERAPEUTICS, INC.; CROWN LABORATORIES, INC.
To: HAYFIN SERVICES LLP, AS ADMINISTRATIVE AGENT
Reel/Frame 070153/0663 →
Security Interest
Feb 7, 2025
From: REVANCE THERAPEUTICS, INC.; BELLUS MEDICAL, LLC; CROWN LABORATORIES, INC.
To: HAYFIN SERVICES LLP, AS ADMINISTRATIVE AGENT
Reel/Frame 070153/0736 →
Security Interest
Feb 17, 2025
From: REVANCE THERAPEUTICS, INC.
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 070239/0739 →